The Potent and Selective Oral STAT6 Degrader, KT-621, Affects Gene Transcripts in Human Keratinocytes as Effectively as Dupilumab, and Blocks Th2 Inflammation in Atopic Dermatitis and Asthma Mouse Models. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s629, 2025. DOI: 10.25251/xbb5zx93. Disponível em: https://skin.dermsquared.com/skin/article/view/3899. Acesso em: 25 may. 2026.